All treatments
Treatment
Veltassa 8.4 g powder for oral suspension clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic confirmatory (Phase III)
A Prospective, double-blind, randomized, single centre trial to evaluate the rate of RAAS inhibitor withdrawal or down-titration in non-dialysis patients with CKD stage IIIB to Vrandomized to Patiromer or placebo
This study looks at how a new medicine, Patiromer, affects potassium levels in people with kidney disease who are also taking blood pressure medication. High potassium can be a problem, so researchers want to see if Patiromer helps patients keep taking their important blood pressure drugs.
For: Hyyperkalemia in CKD stage IIIB to V patientsItaly - Ongoing, recruitingTherapeutic exploratory (Phase II)
Double-blind, placebo-controlled clinical trial to determine the effect of Patiromer on vascular function and its relationship with mineral metabolism parameters
This study looks at how a drug called Patiromer affects blood vessel health in people with long-term kidney disease. We want to see if it improves how flexible their arteries are and how it relates to important body chemicals like calcium and phosphate.
For: Chronic kindney diseaseSpain